This is a working overview of 白蛋白结合, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-19 and is reviewed periodically as new material appears.
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Water and aqueous buffers | Near neutral pH |
| Storage temperature | Minus 20 to minus 80 C | Long-term, lyophilized |
| Analytical method | RP-HPLC | Purity assessment |
| Typical purity | Greater than 95 percent | Research-grade material |
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。
序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
市售注射用制剂通常要求在二至八摄氏度冷藏保存，并避免光照与冻结。部分多剂量笔在首次使用后允许在不超过三十摄氏度的环境中存放有限周数，具体期限由辅料与防腐剂体系决定。反复冻融会促进肽链聚集并改变可见颗粒计数，因此应予避免。冻干粉末在干燥、避光、低温条件下更为稳定。溶液配制后宜使用低吸附容器，以减少肽类在塑料或玻璃表面的损失。
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
== People == Maxim (given name) Maxim (surname) Maxim (musician) Maxim., taxonomic author abbreviation of Karl Maximovich (1827–1891), Russian botanist Maksim, Metropolitan of all Rus, Metropolitan of Kiev (1283–1305) Maksim, Bulgarian Patriarch (1914–2012), Patriarch of the Bulgarian Orthodox Church Maksim, Serbian Patriarch (d. 1680), Patriarch of the Serbian Orthodox Church (1655-1674) Maksim Branković (d. 1516), Serbian Orthodox Metropolitan of Belgrade and Syrmia
=== Digital Tools === Audio-based interventions, primarily telephone consultations, have shown promise as supplements to usual diabetes care. A 2025 systematic review found moderate certainty evidence for modest improvements in glycemic control (A1c reduction of 0.20%), with greater effectiveness when interventions included at least monthly contact and remote monitoring tools.
=== Drug discovery and bio-conjugation === Click chemistry has become a cornerstone in drug discovery and bioconjugation. Its ability to rapidly and selectively form stable covalent bonds has facilitated the development of targeted therapeutics and diagnostic agents. Recent studies have explored the use of click chemistry in creating multifunctional drug delivery systems, enhancing the specificity and efficacy of treatments. The simplicity of click chemistry has had significant impact in many themes, especially pharmaceutical development. Click chemistry been used in numerous drug studies to study their mechanism of action. Discoveries include that salinomycin localizes to lysosomes to initiate ferroptosis in cancer stem cells and that metformin derivatives accumulate in mitochondria to chelate copper(II), affecting metabolism and epigenetic changes downstream in inflammatory macrophages. In combination with combinatorial chemistry, high-throughput screening, and building chemical libraries, click chemistry has hastened new drug discoveries by making each reaction in a multistep synthesis fast, efficient, and predictable.
Complicated silicosis is more common with accelerated silicosis than with the chronic variety. Acute silicosis Silicosis that develops a few weeks to 5 years after exposure to high concentrations of respirable silica dust. This is also known as silicoproteinosis. Symptoms of acute silicosis include more rapid onset of severe disabling shortness of breath, cough, weakness, and weight loss, often leading to death. The x-ray usually reveals a diffuse alveolar filling with air bronchograms, described as a ground-glass appearance, and similar to pneumonia, pulmonary edema, alveolar hemorrhage, and alveolar cell lung cancer.
=== Breakdown === The liver is responsible for the breakdown of insulin and other hormones. The liver breaks down bilirubin via glucuronidation, facilitating its excretion into bile. The liver is responsible for the breakdown and excretion of many waste products. It plays a key role in breaking down or modifying toxic substances (e.g., methylation) and most medicinal products in a process called drug metabolism. This sometimes results in toxication, when the metabolite is more toxic than its precursor. Preferably, the toxins are conjugated to avail excretion in bile or urine. The liver converts ammonia into urea as part of the ornithine cycle or the urea cycle, and the urea is excreted in the urine.
Sources: en.wikipedia.org
== Works == Macleod was a prolific writer. His first academic article was a paper on phosphorus content in muscles published in 1899. During his career he authored or co-authored over 200 papers and eleven books. Among them are:
=== Centrazbat '97 === In September 1997, the 82nd traveled to Kazakhstan and Uzbekistan for CENTRAZBAT '97. Paratroopers from Ft. Bragg, NC flew 8,000 miles on US Air Force C-17s and jumped into an airfield in Shimkent, Kazakhstan. Forty soldiers from the three republics joined 500 paratroopers on the exercise-opening jump. Marine Gen. John Sheehan, then-commander in chief of the Atlantic Command, was first out of the aircraft. The 82nd joined units from Kyrgyzstan, Turkey, and Russia in the two-week-long NATO training mission. Members of the international press and local reporters from WRAL-TV and the Fayetteville Observer were embedded with the 82nd Airborne.
=== Economic rehabilitation === Immediate relief measures were determined two days after the tragedy. These measures commenced in 1985 when food was distributed for a short period along with ration cards. Madhya Pradesh government's finance department allocated ₹874 million (US$9.1 million) for victim relief in July 1985. Widow pension of ₹200 (US$2.10)/per month (later ₹750 (US$7.80)) was provided. The government also decided to pay ₹1,500 (US$16) to families with monthly income ₹500 (US$5.20) or less. As a result of the interim relief, more children were able to attend school, more money was spent on treatment and food, and housing also eventually improved. From 1990 interim relief of ₹200 (US$2.10) was paid to everyone in the family who was born before the disaster. The total compensation, including interim relief for personal injury, was for the majority ₹25,000 (US$260). For death claims, the average sum paid out was ₹62,000 (US$640). Each claimant was to be categorised by a doctor. In court, the claimants were expected to prove "beyond reasonable doubt" that death or injury in each case was attributable to exposure. In 1992, 44 percent of the claimants still had to be medically examined. By the end of October 2003, according to the Bhopal Gas Tragedy Relief and Rehabilitation Department, compensation had been awarded to 554,895 people for injuries received and 15,310 survivors of those killed. The average amount to families of the dead was $2,200. In 2007, 1,029,517 cases were registered and decided.
5-Hydroxytryptophan (5-HTP) can also be administered through a transdermal patch, which was launched in the United Kingdom in early 2014. Rivastigmine, an Alzheimer's treatment medication, was released in patch form in 2007 under the brand name Exelon. In December 2019, Robert S. Langer and his team developed and patented a technique whereby transdermal patches could be used to label people with invisible ink in order to store medical information subcutaneously. This was presented as a boon to "developing nations" where lack of infrastructure means an absence of medical records. The technology uses a "quantum dot dye that is delivered along with a vaccine". Caffeine patches, designed to deliver caffeine to the body through the skin.
=== Target products and services === Global sales of proprietary drugs are estimated at $735 billion in 2010, or almost 90% of the total pharma market. Global sales of generics are about $100 billion, or just over 10% of the total pharma market. Due to the much lower unit price, their market share will be close to 30% on an API volume/volume basis.
Sources: en.wikipedia.org
Fuchs dystrophy, also referred to as Fuchs endothelial corneal dystrophy (FECD) and Fuchs endothelial dystrophy (FED), is a slowly progressing corneal dystrophy that usually affects both eyes and is slightly more common in women than in men. Although early signs of Fuchs dystrophy are sometimes seen in people in their 30s and 40s, the disease rarely affects vision until people reach their 50s and 60s.
While some biological materials such as collagen, microtubules, and muscle myosin can produce SHG signals, even water can become ordered and produce second-harmonic signal under certain conditions, which allows SH microscopy to image surface potentials without any labeling molecules. The SHG pattern is mainly determined by the phase matching condition. A common setup for an SHG imaging system will have a laser scanning microscope with a titanium sapphire mode-locked laser as the excitation source. The SHG signal is propagated in the forward direction. However, some experiments have shown that objects on the order of about a tenth of the wavelength of the SHG produced signal will produce nearly equal forward and backward signals.
== Treatment == No cure for scleroderma is known, though treatments exist for some of the symptoms, including drugs that soften the skin and reduce inflammation. Some patients may benefit from exposure to heat. Holistic care of patients comprising patient education tailored to patients' education level is useful in view of the complex nature of the disease symptoms and progress.
Technetium (43Tc) is one of the two elements with Z < 83 that have no stable isotopes; the other such element is promethium. It is primarily artificial, with only trace quantities existing in nature produced by spontaneous fission (there are an estimated 2.5×10−13 grams of 99Tc per gram of pitchblende) or neutron capture by molybdenum. The element was first obtained in 1936 from bombarded molybdenum, the first artificial element to be produced. The most stable radioisotopes are 97Tc (half-life of 4.21 million years), 98Tc (half-life: 4.2 million years), and 99Tc (half-life: 211,100 years). Given that their stated uncertainties are 16 and 30 times their difference, the half-lives of 97Tc and 98Tc are statistically indistinguishable. Thirty-three other radioisotopes have been characterized with atomic masses ranging from 85Tc to 120Tc. Those with half-lives more than an hour have masses 93 to 96. Technetium also has numerous meta states. 97mTc is the most stable, with a half-life of 91.1 days (0.097 MeV), followed by 95mTc (half-life: 62.0 days, 0.039 MeV) and 99mTc (half-life: 6.01 hours, 0.143 MeV). 99mTc emits only gamma rays while decaying to 99Tc. For isotopes lighter than 98Tc, the primary decay mode is electron capture to isotopes of molybdenum. For the heavier isotopes, the primary mode is beta emission to isotopes of ruthenium, with the exception that 98Tc and 100Tc can decay both by beta emission and electron capture. Technetium-99m is the technetium isotope employed in the nuclear medicine industry.
Early drafts of the European Union's General Data Protection Regulation in 2016 included an explicit statement that this right exists. Industry experts noted that this is an unsolved problem with no solution in sight. Regulators argued that nevertheless the harm is real: if the problem has no solution, the tools should not be used. DARPA established the XAI ("Explainable Artificial Intelligence") program in 2014 to try to solve these problems. Several approaches aim to address the transparency problem. SHAP enables to visualise the contribution of each feature to the output. LIME can locally approximate a model's outputs with a simpler, interpretable model. Multitask learning provides a large number of outputs in addition to the target classification. These other outputs can help developers deduce what the network has learned. Deconvolution, DeepDream and other generative methods can allow developers to see what different layers of a deep network for computer vision have learned, and produce output that can suggest what the network is learning. For generative pre-trained transformers, Anthropic developed a technique based on dictionary learning that associates patterns of neuron activations with human-understandable concepts.
Sources: en.wikipedia.org
Long-term storage is usually at minus 20 to minus 80 degrees Celsius in a sealed, desiccated container. Working aliquots can be held briefly at 2 to 8 degrees Celsius.
Repeated temperature cycling can promote aggregation and peptide degradation. Dividing material into single-use aliquots limits this risk.
Mass spectrometry is commonly used to confirm molecular mass and detect structural modifications. It is often paired with chromatographic purity assessment.
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.